Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Melissa N. Garcia is active.

Publication


Featured researches published by Melissa N. Garcia.


Emerging Infectious Diseases | 2017

Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood

Kristy O. Murray; Rodion Gorchakov; Anna R. Carlson; Rebecca Berry; Lilin Lai; Muktha S Natrajan; Melissa N. Garcia; Armando Correa; Shital M. Patel; Kjersti Aagaard; Mark J. Mulligan

Infection with Zika virus is an emerging public health crisis. We observed prolonged detection of virus RNA in vaginal mucosal swab specimens and whole blood for a US traveler with acute Zika virus infection who had visited Honduras. These findings advance understanding of Zika virus infection and provide data for additional testing strategies.


American Journal of Tropical Medicine and Hygiene | 2015

Case Report: Evidence of Autochthonous Chagas Disease in Southeastern Texas

Melissa N. Garcia; David Aguilar; Rodion Gorchakov; Susan N. Rossmann; Susan P. Montgomery; Hilda Rivera; Laila Woc-Colburn; Peter J. Hotez; Kristy O. Murray

Autochthonous transmission of Trypanosoma cruzi in the United States is rarely reported. Here, we describe five newly identified patients with autochthonously acquired infections from a small pilot study of positive blood donors in southeast Texas. Case-patients 1-4 were possibly infected near their residences, which were all in the same region ∼100 miles west of Houston. Case-patient 5 was a young male with considerable exposure from routine outdoor and camping activities associated with a youth civic organization. Only one of the five autochthonous case-patients received anti-parasitic treatment. Our findings suggest an unrecognized risk of human vector-borne transmission in southeast Texas. Education of physicians and public health officials is crucial for identifying the true disease burden and source of infection in Texas.


PLOS ONE | 2014

Survival Analysis, Long-Term Outcomes, and Percentage of Recovery up to 8 Years Post-Infection among the Houston West Nile Virus Cohort

Kristy O. Murray; Melissa N. Garcia; Mohammad H. Rahbar; Diana Martinez; Salma A. Khuwaja; Raouf R. Arafat; Susan N. Rossmann

In 2012, we witnessed a resurgence of West Nile virus (WNV) in the United States, with the largest outbreak of human cases reported since 2003. WNV is now endemic and will continue to produce epidemics over time, therefore defining the long-term consequences of WNV infection is critical. Over a period of eight years, we prospectively followed a cohort of 157 WNV-infected subjects in the Houston metropolitan area to observe recovery over time and define the long-term clinical outcomes. We used survival analysis techniques to determine percentage of recovery over time and the effects of demographic and co-morbid conditions on recovery. We found that 40% of study participants continued to experience symptoms related to their WNV infection up to 8 years later. Having a clinical presentation of encephalitis and being over age 50 were significantly associated with prolonged or poor recovery over time. Since the health and economic impact as a result of prolonged recovery, continued morbidity, and related disability is likely substantial in those infected with WNV, future research should be aimed at developing effective vaccines to prevent illness and novel therapeutics to minimize morbidity, mortality, and long-term complications from infection.


American Journal of Tropical Medicine and Hygiene | 2015

Long-Term Neurological Outcomes in West Nile Virus–Infected Patients: An Observational Study

Vicki Miller; Melissa N. Garcia; Rodrigo Hasbun; Lucrecia Salazar; Mazen M. Dimachkie; Kristy O. Murray

The Houston West Nile Cohort (HWNC) was founded in 2002 when West Nile virus (WNV) reached Houston, TX. The long-term outcomes following WNV infection are still mostly unknown, though neurological abnormalities up to 1 year postinfection have been documented. We report an observational study of neurological abnormalities at 1–3 and 8–11 years following WNV infection in the HWNC. We conducted standard neurological examinations at two separate time points to assess changes in neurological status over time. The majority of patients (86%, 30/35) with encephalitis had abnormal neurological exam findings at the time of the first assessment compared with uncomplicated fever (27%, 3/11) and meningitis (36%, 5/14) cases. At the time of the second assessment, 57% (4/7) of West Nile fever (WNF), 33% (2/6) of West Nile meningitis (WNM), and 36% (5/14) of West Nile encephalitis (WNE) had developed new neurological complications. The most common abnormalities noted were tandem gait, hearing loss, abnormal reflexes, and muscle weakness. Long-term neurological abnormalities were most commonly found in patients who experienced primary WNV encephalitis. New abnormalities may develop over time regardless of initial clinical infection. Future studies should aim to differentiate neurological consequences due to WNV neuroinvasive infection versus neurological decline related to comorbid conditions.


Viral Immunology | 2014

Evaluation of Prolonged Fatigue Post–West Nile Virus Infection and Association of Fatigue with Elevated Antiviral and Proinflammatory Cytokines

Melissa N. Garcia; Anne M. Hause; Christopher Walker; Jordan S. Orange; Rodrigo Hasbun; Kristy O. Murray

This study aimed to characterize fatigue postinfection among study participants with a history of West Nile virus (WNV) infection and determine whether antiviral and pro-inflammatory cytokines were significantly elevated in those reporting prolonged fatigue. We found that 31% (44/140) of study participants experienced prolonged (more than 6 months) fatigue postinfection, with an average length of fatigue duration of 5 years. Females, those younger than 50 years of age, and those with symptomatic clinical WNV disease were significantly more likely to report fatigue. Pro-inflammatory and antiviral cytokines (granulocyte macrophage colony stimulating factor, interferon-γ, interferon-γ inducing protein 10, interleukin 2, interleukin 6, and interleukin 12p70) were significantly elevated in those reporting fatigue postinfection compared to those not reporting fatigue. Clinicians should consider history of WNV infection as a possible factor when evaluating causes of prolonged fatigue following a febrile viral illness in their patients.


American Journal of Tropical Medicine and Hygiene | 2013

Persistence of Detectable Immunoglobulin M Antibodies Up to 8 Years After Infection with West Nile Virus

Kristy O. Murray; Melissa N. Garcia; Chris Yan; Rodion Gorchakov

In Houston, we have been monitoring the immune response to West Nile virus (WNV) infection in a large cohort of study participants since 2002. Using enzyme-linked immunosorbent assay techniques, serum from 163 participants was tested for the presence of anti-WNV immunoglobulin M (IgM) and IgG antibodies. We found that 42%, 34%, and 23% of study participants had either positive or equivocal results when tested for anti-WNV IgM antibodies approximately 1, 6, and 8 years post-infection, respectively. Conversely, almost one-half of study participants (46%) had undetectable anti-WNV IgG antibodies by 8 years post-infection. This study is the first study to calculate the slope of the rate of decay of antibodies over time as well as show persistence of detectable anti-WNV IgM antibodies up to 8 years post-infection. These findings warrant additional investigation, particularly the determination of whether persistence of IgM is related to persistent infection with WNV.


Clinical and Vaccine Immunology | 2015

Systems immunology reveals markers of susceptibility to West Nile virus infection.

Feng Qian; Gautam Goel; Hailong Meng; Xiaomei Wang; Fuping You; Lesley Devine; Melissa N. Garcia; Kristy O. Murray; Christopher R. Bolen; Renaud Gaujoux; Shai S. Shen-Orr; David A. Hafler; Erol Fikrig; Ramnik J. Xavier; Steven H. Kleinstein; Ruth R. Montgomery

ABSTRACT West Nile virus (WNV) infection is usually asymptomatic but can cause severe neurological disease and death, particularly in older patients, and how individual variations in immunity contribute to disease severity is not yet defined. Animal studies identified a role for several immunity-related genes that determine the severity of infection. We have integrated systems-level transcriptional and functional data sets from stratified cohorts of subjects with a history of WNV infection to define whether these markers can distinguish susceptibility in a human population. Transcriptional profiles combined with immunophenotyping of primary cells identified a predictive signature of susceptibility that was detectable years after acute infection (67% accuracy), with the most prominent alteration being decreased IL1B induction following ex vivo infection of macrophages with WNV. Deconvolution analysis also determined a significant role for CXCL10 expression in myeloid dendritic cells. This systems analysis identified markers of pathogenic mechanisms and offers insights into potential therapeutic strategies.


Epidemiology and Infection | 2016

Trypanosoma cruzi screening in Texas blood donors, 2008–2012

Melissa N. Garcia; Laila Woc-Colburn; Susan N. Rossmann; R. L. Townsend; S. L. Stramer; M. Bravo; H. Kamel; R. Beddard; M. Townsend; R. Oldham; Maria Elena Bottazzi; Peter J. Hotez; Kristy O. Murray

Chagas disease is an important emerging disease in Texas that results in cardiomyopathy in about 30% of those infected with the parasite Trypanosoma cruzi. Between the years 2008 and 2012, about 1/6500 blood donors were T. cruzi antibody-confirmed positive. We found older persons and minority populations, particularly Hispanic, at highest risk for screening positive for T. cruzi antibodies during routine blood donation. Zip code analysis determined that T. cruzi is associated with poverty. Chagas disease has a significant disease burden and is a cause of substantial economic losses in Texas.


PLOS ONE | 2016

West Nile Virus Retinopathy and Associations with Long Term Neurological and Neurocognitive Sequelae

Rodrigo Hasbun; Melissa N. Garcia; Judianne Kellaway; Laura D. Baker; Lucrecia Salazar; Steven Paul Woods; Kristy O. Murray

West Nile virus (WNV) has emerged as an important vector-borne pathogen in North America, with more than 3 million estimated to have been infected. Retinopathy from WNV infection has been previously reported in acute cases, though those prior reports did not evaluate the risk of retinopathy based on clinical severity of neurologic disease. The purpose of this cross-sectional study was to perform comprehensive ophthalmological and neurological examinations on 111 patients with a history of West Nile virus infection and describe the ocular manifestations. Out of 111 patients, 27 (24%) had evidence for West Nile virus associated retinopathy (WNVR); this observation was higher (49%) in those patients who initially presented with encephalitis. Individuals with WNVR had more frequent involvement of the macula and peripheral involvement compared to those patients without WNVR (p<0.05). WNVR was also associated with a greater likelihood of abnormal reflexes on neurological exam, poorer learning, greater dependence in activities of daily living, and lower quality of life (p<0.05). WNVR was seen more frequently in elderly patients (age > 60 years), and was associated with higher rates of diabetes mellitus and a history of encephalitis (p<0.05). A multivariable logistic regression revealed that only a history of encephalitis was independently associated with WNVR [Adjusted Odds Ratio = 4.9 (1.8–13.2); p = 0.001]. Our study found that WNVR occurs in one fourth of patients with a history of WNV infection and is more frequently observed in those with apparent severe neurological sequelae (e.g., encephalitis). The clinical relevance of WNVR was supported by its associations with dependence in activities of daily living and lower quality of life. This unique evaluation of WNV patients included fundoscopic examinations and their associations with neurologic impairment. Our findings can be used during ophthalmological consultation for the evaluation, treatment and rehabilitation phases of care for WNV patients.


PLOS Neglected Tropical Diseases | 2015

Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States.

Melissa N. Garcia; Laila Woc-Colburn; David Aguilar; Peter J. Hotez; Kristy O. Murray

Chagas disease (Trypanosoma cruzi infection) has recently been identified as an important neglected tropical disease in the United States. Anecdotally referred to as a “silent killer,” it leads to the development of potentially fatal cardiac disease in approximately 30% of those infected. In an attempt to better understand the potential of Chagas disease as a significant underlying cause of morbidity in Texas, we performed a historical literature review to assess disease burden. Human reports of triatomine bites and disease exposure were found to be prevalent in Texas. Despite current beliefs that Chagas disease is a recently emerging disease, we report historical references dating as far back as 1935. Both imported cases and autochthonous transmission contribute to the historical disease burden in Texas. We end by discussing the current knowledge gaps, and recommend priorities for advancing further epidemiologic studies and their policy implications.

Collaboration


Dive into the Melissa N. Garcia's collaboration.

Top Co-Authors

Avatar

Kristy O. Murray

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Rodion Gorchakov

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Peter J. Hotez

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Susan N. Rossmann

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Laila Woc-Colburn

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Rodrigo Hasbun

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Sarah M. Gunter

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

David Aguilar

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric L. Brown

University of Texas Health Science Center at Houston

View shared research outputs
Researchain Logo
Decentralizing Knowledge